Activation of natural killer cells via the p75 interleukin 2 receptor.
Open Access
- 1 July 1989
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 170 (1) , 291-296
- https://doi.org/10.1084/jem.170.1.291
Abstract
The IL-2R is composed of at least two subunits, the p55 (CD25/Tac) and p75 glycoproteins. The p75 IL-2R is expressed preferentially on resting human peripheral blood NK cells, but is not detected on substantial proportions of T and B lymphocytes, monocytes, or granulocytes. Anti-p75 IL-2R mAb substantially inhibits the early events associated with NK cell activation by IL-2, including inhibition of cytotoxic activity and induction of the CD69 early activation antigen. While anti-p55 IL-2R mAb alone failed to substantially inhibit the initial events of IL-2 stimulation, maximal inhibition of IL-2-induced cytotoxicity and proliferation was achieved by combining both anti-p55 IL-2R and anti-p75 IL-2R. Collectively, results from the present studies directly implicate the p75 IL-2R as the structure predominantly responsible for IL-2 activation of NK cells.This publication has 18 references indexed in Scilit:
- Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor.The Journal of Experimental Medicine, 1989
- Possible association between IL-2 receptors and class I HLA molecules on T cells.The Journal of Immunology, 1988
- Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen.The Journal of Experimental Medicine, 1988
- The Interleukin 2 ReceptorPublished by Elsevier ,1988
- In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin-2 and LAK cell therapy.Journal of Clinical Oncology, 1987
- Flow cytometric resonance energy transfer measurements support the association of a 95-kDa peptide termed T27 with the 55-kDa Tac peptide.Proceedings of the National Academy of Sciences, 1987
- The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells.Proceedings of the National Academy of Sciences, 1987
- Contribution of a p75 interleukin 2 binding peptide to a high-affinity interleukin 2 receptor complex.Proceedings of the National Academy of Sciences, 1987
- Response of resting human peripheral blood natural killer cells to interleukin 2.The Journal of Experimental Medicine, 1984
- Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.The Journal of Immunology, 1983